Literature DB >> 30599065

Multiple endocannabinoid-mediated mechanisms in the regulation of energy homeostasis in brain and peripheral tissues.

Inigo Ruiz de Azua1, Beat Lutz2.   

Abstract

The endocannabinoid (eCB) system is widely expressed in many central and peripheral tissues, and is involved in a plethora of physiological processes. Among these, activity of the eCB system promotes energy intake and storage, which, however, under pathophysiological conditions, can favour the development of obesity and obesity-related disorders. It is proposed that eCB signalling is evolutionary beneficial for survival under periods of scarce food resources. Remarkably, eCB signalling is increased both in hunger and in overnutrition conditions, such as obesity and type-2 diabetes. This apparent paradox suggests a role of the eCB system both at initiation and at clinical endpoint of obesity. This review will focus on recent findings about the role of the eCB system controlling whole-body metabolism in mice that are genetically modified selectively in different cell types. The current data in fact support the notion that eCB signalling is not only engaged in the development but also in the maintenance of obesity, whereby specific cell types in central and peripheral tissues are key sites in regulating the entire body's energy homeostasis.

Entities:  

Keywords:  2-Arachidonoyl glycerol; Anandamide; Cannabinoid type 1 receptor; Endocannabinoid system; Energy balance; Energy expenditure; Feeding behaviour; Metabolic syndrome; Obesity, Type-2 diabetes; Peripheral CB1 antagonist; Rimonabant

Mesh:

Substances:

Year:  2019        PMID: 30599065     DOI: 10.1007/s00018-018-2994-6

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  22 in total

1.  Transient gain of function of cannabinoid CB1 receptors in the control of frontocortical glucose consumption in a rat model of Type-1 diabetes.

Authors:  Joana Reis Pedro; Liane I F Moura; Ângela Valério-Fernandes; Filipa I Baptista; Joana M Gaspar; Bárbara S Pinheiro; Cristina Lemos; Fernanda Neutzling Kaufmann; Carla Morgado; Carla S da Silva-Santos; Isaura Tavares; Samira G Ferreira; Eugénia Carvalho; António F Ambrósio; Rodrigo A Cunha; João M N Duarte; Attila Köfalvi
Journal:  Brain Res Bull       Date:  2020-05-16       Impact factor: 4.077

2.  Anti-obesity therapy with peripheral CB1 blockers: from promise to safe(?) practice.

Authors:  Carmelo Quarta; Daniela Cota
Journal:  Int J Obes (Lond)       Date:  2020-04-21       Impact factor: 5.095

3.  Pan-phylum In Silico Analyses of Nematode Endocannabinoid Signalling Systems Highlight Novel Opportunities for Parasite Drug Target Discovery.

Authors:  Bethany A Crooks; Darrin Mckenzie; Luke C Cadd; Ciaran J McCoy; Paul McVeigh; Nikki J Marks; Aaron G Maule; Angela Mousley; Louise E Atkinson
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-01       Impact factor: 6.055

4.  Identification of CB1 Ligands among Drugs, Phytochemicals and Natural-Like Compounds: Virtual Screening and In Vitro Verification.

Authors:  Adam Stasiulewicz; Anna Lesniak; Piotr Setny; Magdalena Bujalska-Zadrożny; Joanna I Sulkowska
Journal:  ACS Chem Neurosci       Date:  2022-10-05       Impact factor: 5.780

Review 5.  Lipokines and Thermogenesis.

Authors:  Matthew D Lynes; Sean D Kodani; Yu-Hua Tseng
Journal:  Endocrinology       Date:  2019-10-01       Impact factor: 4.736

6.  Influence of Cannabinoid Receptor Deficiency on Parameters Involved in Blood Glucose Regulation in Mice.

Authors:  Juliane Zibolka; Anja Wolf; Lisa Rieger; Candy Rothgänger; Anne Jörns; Beat Lutz; Andreas Zimmer; Faramarz Dehghani; Ivonne Bazwinsky-Wutschke
Journal:  Int J Mol Sci       Date:  2020-04-30       Impact factor: 5.923

Review 7.  A Guide to Targeting the Endocannabinoid System in Drug Design.

Authors:  Adam Stasiulewicz; Katarzyna Znajdek; Monika Grudzień; Tomasz Pawiński; And Joanna I Sulkowska
Journal:  Int J Mol Sci       Date:  2020-04-16       Impact factor: 5.923

8.  Neurobiology of cannabinoid receptor signaling
.

Authors:  Beat Lutz
Journal:  Dialogues Clin Neurosci       Date:  2020-09       Impact factor: 5.986

9.  Involvement of cannabinoid type 1 receptor in fasting-induced analgesia.

Authors:  Jeong-Yun Lee; Grace J Lee; Ayumi Nakamura; Pa Reum Lee; Yeajin Kim; Chan Hee Won; Hidemasa Furue; Seog Bae Oh
Journal:  Mol Pain       Date:  2020 Jan-Dec       Impact factor: 3.395

10.  Reversal of diet-induced hepatic steatosis by peripheral CB1 receptor blockade in mice is p53/miRNA-22/SIRT1/PPARα dependent.

Authors:  Shahar Azar; Shiran Udi; Adi Drori; Rivka Hadar; Alina Nemirovski; Kiran V Vemuri; Maya Miller; Dana Sherill-Rofe; Yhara Arad; Devorah Gur-Wahnon; Xiaoling Li; Alexandros Makriyannis; Danny Ben-Zvi; Yuval Tabach; Iddo Z Ben-Dov; Joseph Tam
Journal:  Mol Metab       Date:  2020-09-26       Impact factor: 7.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.